131 – 140 of 876
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
evoke and evoke+ : design of two large-scale, double-blind, placebo-controlled, phase 3 studies evaluating efficacy, safety, and tolerability of semaglutide in early-stage symptomatic Alzheimer’s disease
(
- Contribution to journal › Article
-
Mark
Benchmarking Alzheimer’s disease prediction : personalised risk assessment using polygenic risk scores across various methodologies and genome-wide studies
(
- Contribution to journal › Article
-
Mark
Updated appropriate use criteria for amyloid and tau PET : A report from the Alzheimer's Association and Society for Nuclear Medicine and Molecular Imaging Workgroup
(
- Contribution to journal › Scientific review
-
Mark
Mental health service users’ experiences of everyday occupations while attending day centres during the transition into retirement age
(
- Contribution to journal › Article
-
Mark
Varus alignment of the hip and knee 2 years after anterior cruciate ligament injury is associated with medial tibiofemoral osteoarthritis 3 years later
(
- Contribution to journal › Article
-
Mark
Sedentary behaviour and level of physical activity among people with post COVID-19 condition : associated factors and changes over time
(
- Contribution to journal › Article
-
Mark
Structured assessments on the desire for activities – ‘Why wish for what I can’t do?’
(
- Contribution to journal › Article
-
Mark
Lipid-induced condensate formation from the Alzheimer’s Aβ peptide triggers amyloid aggregation
(
- Contribution to journal › Article
-
Mark
Plasma p-tau217 in Alzheimer's disease : Lumipulse and ALZpath SIMOA head-to-head comparison
(
- Contribution to journal › Article
-
Mark
The impact of disease activity and interferon-α on the nervous system in systemic lupus erythematosus
(
- Contribution to journal › Article